SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-033331
Filing Date
2023-06-01
Accepted
2023-06-01 16:19:36
Documents
2
Period of Report
2023-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1567
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3361
  Complete submission text file 0001209191-23-033331.txt   6281
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Issuer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O LANDOS BIOPHARMA, INC. P.O. BOX 11239 BLACKSBURG VA 24062
Business Address
Batycky Alka (Reporting) CIK: 0001978041 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39971 | Film No.: 23984957